According to the World Health Organization, over 40% of the world’s population is at risk from dengue fever – and it’s the leading cause of death among children in some Latin American and Asian countries. But there’s hope for a dengue-free future – because for the first time since the disease was identified 70 years ago, scientists have developed an experimental vaccine for the devastating disease. French pharmaceutical company Sanofi recently announced completion of a late-stage vaccine trial in Southeast Asia which reduced infection rates by 56% in children.

Dengue fever, Dengue fever vaccine, dengue fever cure, dengue fever trials, dengue fever prevention, mosquito spread disease, new vaccine trials, trials for dengue fever, Sanofi, French Sanofi, Sanofi vaccinations, Sanofi dengue fever trials, Sanofi dengue fever, Philippines dengue fever, Latin America dengue fever, Asian dengue fever, dengue fever deaths, dengue fever sicknessImage via John Tann

Cases of dengue fever, which is spread by mosquitos and can cause fever-like symptoms that can ultimately lead to a deadly hemorrhagic fever, have been increasing dramatically over the past 50 years, making the need for a vaccination more important than ever. Sanofi tested the vaccine on over 10,000 kids from Indonesia, Malaysia, the Philippines, Thailand and Vietnam. The vaccination showed a promising improvement in dengue fever infection rates, marking a huge step in prevention development for a disease that has managed to allude a cure despite decades of attempts to stop it.

Related: Dengue Fever Threatens the 2014 World Cup in Brazil

“This achievement is the result of more than 20 years of work in the field of dengue, collaborating with investigators, volunteers, authorities, scientific experts and international organizations. Our goal is to make dengue the next vaccine-preventable disease and to support the World Health Organization’s ambition to reduce dengue mortality by 50 percent and morbidity by 25 percent by 2020,” said Sanofi Pasteur, President of Sanofi, and Olivier Charmeil, CEO of the company, in a joint statement. If all goes according to plan with the vaccine, the WHO and thousands of children around the world might just get their wish.

Via Philippine Daily Inquirer

Lead Photo via Shutterstock